THEREFORE BE IT RESOLVED that BPW Canada urges the Government of Canada to investigate all incidents where Pharmaceutical companies may be promoting products, usually new drugs, and where a researcher questions the effect of the product on the health of the patient, and the pharmaceutical company retaliates by using its clout to silence anyone questioning its products by threatening that person with legal action and by withdrawing its support of the hospital, health care establishment or research facility. FURTHER BE IT RESOLVED that BPW Canada recommends that, if the investigation proves that undue influence was used, that the pharmaceutical company be fined.